Qube Research & Technologies (QRT)’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-184,514
Closed -$11.8M – 4159
2026
Q1
$11.8M Buy
184,514
+109,106
+145% +$9.95M 0.01% 1176
2025
Q4
$9.81M Buy
75,408
+57,809
+328% +$7.93M 0.01% 1359
2025
Q3
$1.9M Buy
+17,599
New +$1.92M ﹤0.01% 2259
2025
Q2
– Sell
-89,775
Closed -$7.95M – 4029
2025
Q1
$7.95M Buy
89,775
+75,341
+522% +$6.54M 0.01% 1273
2024
Q4
$1.11M Sell
14,434
-1,075
-7% -$75.1K ﹤0.01% 2126
2024
Q3
$658K Buy
15,509
+3,721
+32% +$126K ﹤0.01% 2181
2024
Q2
$308K Buy
+11,788
New +$223K ﹤0.01% 2297
2023
Q4
– Sell
-1,939
Closed -$7.06K – 4791
2023
Q3
$7.06K Buy
+1,939
New +$10.6K ﹤0.01% 3388
2022
Q2
– Sell
-8,004
Closed -$811K – 3196
2022
Q1
$811K Buy
8,004
+2,782
+53% +$309K 0.01% 1281
2021
Q4
$769K Buy
+5,222
New +$1.17M 0.01% 1339

Other funds holding WGS

Qube Research & Technologies (QRT)'s WGS Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 184,514 shares — an estimated $11.8M sold.

Qube Research & Technologies (QRT) first reported a position in WGS in Q4 2021 and held it in 10 quarters. The position peaked at $11.8M in Q1 2026. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 184,514 GeneDx Holdings shares in Q2 2026, an estimated $11.8M.
  • Qube Research & Technologies (QRT) first reported a position in GeneDx Holdings in Q4 2021 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s GeneDx Holdings position peaked at $11.8M in Q1 2026.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.